% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • semiequipmentgodoftheyear semiequipmentgodoftheyear Jun 16, 2013 9:38 PM Flag

    5 of Last Week's Biggest Winners

    Avanir soared after Mizuho initiated coverage of the biotech with a buy rating. Avanir also moved higher earlier this month after the FDA approved an accelerated development pathway for its lead candidate. Shares would have to more than double from here to hit Mizuho's price target of $10.

    Sentiment: Strong Buy